Simvastatin is marketed under the trade name Zocor™ and is often prescribed in combination with ezetimibe (Zetia) to treat dyslipidemia. This drug combination is known commercially as Vytorin or Inegy. Simvastatin also suppresses TNF-induced NF-κB activation, which potentiates apoptosis in human myeloid leukemia cells and thus, may be useful in treating cancer.
Product Details
| Alternative Name: | (βR,δR,1S,2S,6R,8S,8aR)-8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2,6-dimethyl-1-naphthaleneheptanoic acid . monosodium salt |
| |
| Formula: | C25H39O6 . Na |
| |
| MW: | 458.6 |
| |
| CAS: | 101314-97-0 |
| |
| Purity: | ≥97% (HPLC) |
| |
| Appearance: | White powder solid. |
| |
| Solubility: | Soluble in water. |
| |
| Shipping: | Ambient Temperature |
| |
| Short Term Storage: | -20°C |
| |
| Long Term Storage: | -80°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
